Annexon (ANNX) Other financing activities (2021 - 2026)

Annexon's (ANNX) quarterly Other financing activities came in at $936000.0 in Q1 2026, up 1409.68% year-on-year from $62000.0 in Q1 2025, and down 2.4% quarter-over-quarter from $959000.0 in Q4 2025.

Annexon (ANNX) Other financing activities (2021 - 2026) Analysis & Trends

Annexon's Other financing activities history runs 6 years deep, the most recent figure standing at $936000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities rose 1409.68% year-over-year to $936000.0 in Q1 2026; TTM through Mar 2026 was $2.5 million, a 561.27% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 31.41% from the prior year.
  • Other financing activities eased to $936000.0 in Q1 2026 per ANNX's latest filing, from $959000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $959000.0 in Q4 2025 and bottomed at -$702000.0 in Q2 2024.
  • The 5-year median for Other financing activities is $115500.0 (2023), against an average of $247312.5.
  • Across the five-year window, Other financing activities slumped 2818.75% in 2023 and surged 1409.68% in 2026, its largest moves.
  • Year by year, Other financing activities stood at $16000.0 in 2022, then slumped by 2818.75% to -$435000.0 in 2023, then soared by 172.18% to $314000.0 in 2024, then jumped by 205.41% to $959000.0 in 2025, then fell by 2.4% to $936000.0 in 2026.
  • Per Business Quant, the three latest ANNX Other financing activities figures stand at $936000.0 (Q1 2026), $959000.0 (Q4 2025), and $478000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Annexon 1.02 Bn 798.41 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 936,000.00
Mar 31, 2026 936,000.00
Dec 31, 2025 959,000.00
Dec 31, 2025 959,000.00
Sep 30, 2025 478,000.00
Sep 30, 2025 478,000.00
Jun 30, 2025 120,000.00
Jun 30, 2025 120,000.00
Mar 31, 2025 62,000.00
Mar 31, 2025 62,000.00
Dec 31, 2024 314,000.00
Dec 31, 2024 314,000.00
Sep 30, 2024 703,000.00
Sep 30, 2024 703,000.00
Jun 30, 2024 -702,000.00
Jun 30, 2024 -702,000.00
Mar 31, 2024 917,000.00
Mar 31, 2024 917,000.00
Dec 31, 2023 -435,000.00
Dec 31, 2023 -435,000.00